Skip to content

Author

Zun-Min Zhu

2 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Oct 2026

Real-world cost-effectiveness of sequential therapy of in-class transition to ixazomib versus daratumumab for transplant-ineligible newly diagnosed multiple myeloma in China.

Aim: Expanding treatment options for transplant-ineligible newly diagnosed multiple myeloma (ndMM) in China has increased the need to identify treatment strategies that improve patient outcomes while using healthcare resources efficiently. This study evaluated the cost-effectiveness of in-class transition (iCT) to ixaz...

Gen-Yong Zuo, Ai-Jun Liu, Zun-Min Zhu et al. · 0 citations
Review Open access Sep 2026

Clinical and prognostic significance of CD4 expression in patients with de novo acute myeloid leukemia receiving intensive chemotherapy.

Although the lymphoid marker CD4 is aberrantly expressed in acute myeloid leukemia (AML), its clinical and prognostic significance remains poorly characterized. We retrospectively analyzed 217 patients with de novo AML receiving intensive chemotherapy. The clinical characteristics and survival outcomes were analyzed ac...

Liu Yang, Wei-Ya Li, H. Di et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.